D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
HZNP holding history
Horizon Therapeutics Public Ltd Co in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HZNP overviewAll 13F holders of HZNPFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −4,718,246−100.0% | Sold out | Holders |
| Q3 2023 | 4,718,246 | $545.9M | 0.9% | +1,035,866+28.1% | Added | Holders |
| Q2 2023 | 3,682,380 | $378.7M | 0.6% | +1,457,042+65.5% | Added | Holders |
| Q1 2023 | 2,225,338 | $242.9M | 0.4% | +2,145,248+2,678.5% | Added | Holders |
| Q4 2022 | 80,090 | $9.11M | <0.1% | −334,088−80.7% | Reduced | Holders |
| Q3 2022 | 414,178 | $25.6M | <0.1% | +390,368+1,639.5% | Added | Holders |
| Q2 2022 | 23,810 | $1.90M | <0.1% | −246,964−91.2% | Reduced | Holders |
| Q1 2022 | 270,774 | $28.5M | <0.1% | +124,881+85.6% | Added | Holders |
| Q4 2021 | 145,893 | $15.7M | <0.1% | −109,344−42.8% | Reduced | Holders |
| Q3 2021 | 255,237 | $28.0M | <0.1% | −169,464−39.9% | Reduced | Holders |
| Q2 2021 | 424,701 | $39.8M | <0.1% | −1,192,747−73.7% | Reduced | Holders |
| Q1 2021 | 1,617,448 | $148.9M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.